Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yuping Tongqiao Tablet
- Development stage
- Unknown
- Lead developer
- Yiling Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Yuping Tongqiao Tablet is a traditional Chinese medicine (TCM) formulation developed for the treatment of persistent allergic rhinitis, particularly in patients diagnosed with "lung and spleen deficiency syndrome" according to TCM principles. The product is classified as a natural/herbal drug and has undergone multicenter, randomized, double-blind, placebo-controlled phase II and III clinical trials in China to evaluate its efficacy and safety for this indication. Its mechanism of action is based on TCM theory—aimed at strengthening lung and spleen function to alleviate symptoms such as sneezing, runny nose, nasal congestion, and itching. The specific molecular targets or pharmacological mechanisms are not detailed in available sources; the therapeutic effect is attributed to multi-component herbal synergy typical of TCM formulations[1][2][6].
- Brand names
- Yuping Tongqiao Tablet
- Other names
- 玉屏通窍片
02
Targets
VEGFA (Vascular endothelial growth factor A)IL8 (C-X-C Motif Chemokine Ligand 8)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TLR4 (Toll-like receptor 4)EGFR T790M (Epidermal growth factor receptor T790M mutant)
Beyond the preview
Go deeper on Yuping Tongqiao Tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yuping Tongqiao Tablet.